In a luxurious conference center buzzing with Nobel laureates, biotech executives and Saudi royalty, one number kept surfacing during presentations: eight billion. Not dollars—though investment figures approached that scale—but people. The potential market for healthspan technologies encompasses every human on earth, creating what might be the ultimate investment opportunity of the 21st century.At the Hevolution […]
